Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia
Clinical trial NCT04854889 · TERMINATED
Trial details
- NCT number
- NCT04854889
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-07-26
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.